......		Meeting Location: Emerging Enterprise Center at Foley Hoag the Bay Colony Corporate Center 1000 Winter Street, Suite 4000 (North Entrance) Waltham, MA  Meeting Time: 6:30 - 9:30 pm Meeting Cost: $25 public, $10 students and active military
	Tuesday, October 16, 2007 Biotechnology:  "Moving the Life Sciences from the Research Lab to Industrial Implementation" Meeting Overview The biotech revolution continues its advance into uncharted territory, delivering new applications and linking areas as diverse as genomics/proteomics, medical diagnostics, medical therapeutics, drug delivery, and agribusiness.  Largely due to the Boston area's unparalleled academic infrastructure, the region is home to many of the biotech industry's leaders.  This event will bring together some of those leaders to discuss the industry's relationship to academia and to explore how those links will shape the future emergence of the industry and its effects upon our lives.  The audience will be a mix of leading entrepreneurs and established corporations, academic researchers, venture capitalists, and governmental agents. Keynote:                                                                                                           Robert Coughlin, President of the Massachusetts Biotechnology Council (MBC) Moderator: Barry Karger, Professor, Northeastern University, James L. Waters Chair in Analytical Chemistry Panelists: Steven Tregay, Managing Director, Novartis Option Fund Jonathan Fleming, Managing General Partner, Oxford Biosciences Dennis Crowley, Vice President of Corporate Development and Licensing, Covidien Eric L. Miller, Professor, Department of Electrical and Computer Engineering at Tufts University Robert Coughlin - Keynote As President of the Massachusetts Biotechnology Council, Bob’s mission is to foster a positive environment that enables each biotechnology company to achieve its full potential in making Massachusetts a world center for biotechnology. He has been a Principal at MC Solutions, a corporate consulting and capital management firm, and Susquehanna Capital Management, where he managed five portfolio companies.  He also brings years of experience in business development, sales, and marketing.  From 1991 – 1999, Coughlin worked for Clean Harbors Environmental Services, Inc., where he served as an Account Manager and eventually became a Regional Sales and Marketing Manager. Coughlin was president and co-founder of SportsAttire Incorporated, a technology company supporting the sports apparel industry. Most recently, Coughlin served as the Undersecretary of Business Development in the Executive Office of Housing and Economic Development where he was responsible for the retention, expansion, and recruitment of all business in Massachusetts, with particular focus on the Commonwealth’s five emerging industries. Prior to that role, Coughlin served as a two term legislator from the 11th Norfolk District representing part of Dedham, Walpole, and Westwood.  He served as Vice Chairman of the Joint Committee on Revenue, bringing stability to the tax code and working on legislation such as the economic stimulus bill and streamlined permitting package.  Coughlin was awarded Boston’s “Top 40 Under 40” by the Boston Business Journal in 2005.  He earned a B.S. in Marine Engineering from Massachusetts Maritime Academy in 1991 and is a Lieutenant in the U.S. Naval Reserve.  Barry Karger - Moderator: Dr. Barry Karger holds the James L. Waters Chair in Analytical Chemistry at Northeastern University, and is director of the Barnett Institute of Chemical and Biological Analysis.  Through his academic leadership positions, Dr. Karger actively cultivates the intersection between academic research and industrial/medical application of research driven ideas.  This intersection is at the core of his work performed at Barnett Institute, which has led to more than 900 published papers and 70 patents by the Institute's team of over 60 members. Dr. Karger has been repeatedly recognized by numerous award-granting bodies as a leader in his field.  His large and growing body of published research is heavily oriented toward proteomic analysis - the study of proteins, their structure and functions.  Specifically, Dr. Karger leads a research group aimed at developing new technologies to extract as much information as possible from the exceedingly complex mixture of naturally occurring proteomic samples.  This research advances all aspects of the proteomic workflow, including sample preparation, high-resolution liquid chromatography separations, interfaces to mass spectrometry, mass spectrometric methods, data processing, and database searching.  Dr. Karger received his B.S. in Chemistry from MIT, and his PhD in Chemistry from Cornell University. Steven Tregay - Panelist: Dr. Steven Tregay brings a range of experiences in both biotech and the multi-national pharmaceutical industries including roles in research, business development and venture capital investing. He is a Managing Director of the $200M Novartis Option Fund where he has led the fund’s investment in Adenosine Therapeutics and Cequent Pharmaceuticals, where he also serves on the Board of Directors. Prior to joining the venture group, he was the Executive Director and Head of Strategic Alliances-Oncology, Ophthalmology and Technologies at the Novartis Institutes for BioMedical Research. At Novartis, Dr. Tregay managed a team responsible for identification, negotiation and management of collaborations for the Oncology and Ophthalmology disease areas and the Technology areas including Global Discovery Chemistry; Discovery Technologies; Molecular and Developmental Pathways; Mouse Models of Diseases; Genomic and Proteomics Sciences; Kinase, Protease, and GPRC platforms. Prior to joining Novartis, he had roles in business development at Array BioPharma and prior to Array, Steve worked as a medicinal chemist. Dr. Tregay received his B.S. degree in Chemistry from Davidson College and received his Ph.D. and M.S. in organic chemistry from Harvard University. Jonathan Fleming – Panelist: Jonathan Fleming is the Managing General Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, with offices in Boston and Connecticut. Mr. Fleming has been in the investment business for over twenty years, starting and financing growth companies in the United States, Europe, and Israel. Prior to joining OBP in 1996, he was a Founding General Partner of MVP Ventures in Boston, MA. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming has also co-founded Medica Venture Partners, a venture capital investment firm specializing in early stage healthcare and biotechnology companies in Israel. Mr. Fleming is a co-founder and Chairman of the Board of Memory Pharmaceuticals (NASDAQ: MEMY). He is also Chairman of the Board of BioProcessors Corporation and is a director of several private companies including Leerink Swann, a Boston based investment bank specializing in healthcare companies. Mr. Fleming is a Trustee of the Museum of Science in Boston and a Senior Lecturer at the MIT Sloan School of Business. Mr. Fleming holds a Master’s degree in Public Administration from Princeton University and a Bachelor of Arts degree from the University of California, Berkeley. Dennis Crowley - Panelist: Dennis Crowley is the Vice President of Corporate Development & Licensing at Covidien; a $10B publicly traded medical device company based in Massachusetts.  Covidien was previously known as Tyco Healthcare before separating from Tyco International in June 2007.  Dennis has been with Covidien for over 2 years and, before then, he was with Tyco International for 12 years in various roles within Business Development and Operations. Dennis began his career at Tyco in Corporate Strategy and Business Development for 3 years working on strategic plans and acquisitions.  He then spent 5 years in Europe as Director of M&A for the Flow Control division.  During this tenure, the Flow Control division grew from $100M in revenue to over $2.5B globally.  Dennis returned to Tyco International as Senior Director of M&A for 2 years and then spent 2 years as VP of Operational Excellence for Tyco Engineered Products and Services, a segment of Tyco. Dennis has led or worked on over 50 acquisitions and divestitures in all major regions of the world (e.g. North America, Europe, and Asia) in his career.  The final consideration of these transactions ranges from $10M to over $5B.” Eric L. Miller – Panelist: Eric L. Miller is a professor in the Department of Electrical and Computer Engineering at Tufts University.  He received the S.B. in 1990, the S.M. in 1992, and the Ph.D. degree in 1994 all in Electrical Engineering and Computer Science at the Massachusetts Institute of Technology, Cambridge, MA.  Prior to joining Tufts, he held the ranks of Assistant Professor (1994-2000), Associate Professor (2000-2006) and Professor (2006) of Electrical and Computer Engineering at Northeastern University.  Dr. Miller's research interests include physics-based tomographic image formation and object characterization, inverse problems in general and inverse scattering in particular, regularization, statistical signal and imaging processing, and computational physical modeling.  This work has been carried out in the context of applications including medical imaging (diffuse optical tomography, fluorescence molecular tomography, diagnostic ultrasound for cancer treatment monitoring, and dynamic MRI) and underground imaging (environmental remediation, as well as landmine and unexploded ordnance detection).  His work has been supported by the National Science Foundation, the National Institutes of Health, the Department of Energy, the Department of Defense, as well as various industrial sources.  Dr. Miller has also consulted regularly for organizations in the defense as well as biomedical imbibing industries. Dr. Miller is a member of Tau Beta Pi, Phi Beta Kappa and Eta Kappa Nu. He received the CAREER Award from the National Science Foundation in 1996 and the Outstanding Research Award from the College of Engineering at Northeastern University in 2002.  He is currently serving as an Associate editor for the IEEE Transactions on Geoscience and Remote Sensing and was in the same position at the IEEE Transactions on Image Processing from 1998--2002.  Dr. Miller is the co-general chair of the 2008 IEEE International Geoscience and Remote Sensing Symposium to be held in Boston, MA.
Lawrence C. Grumer | Tel: 617-325-9852 | lgrumer@taacorp.com